Sakar Healthcare Limited (SAKAR) - Total Assets

Latest as of March 2026: Rs4.81 Billion INR ≈ $52.02 Million USD

Based on the latest financial reports, Sakar Healthcare Limited (SAKAR) holds total assets worth Rs4.81 Billion INR (≈ $52.02 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check how aggressively does Sakar Healthcare Limited reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Sakar Healthcare Limited - Total Assets Trend (2010–2026)

This chart illustrates how Sakar Healthcare Limited's total assets have evolved over time, based on quarterly financial data. Explore Sakar Healthcare Limited strategic investment ratio to see how much of total assets are deployed in long-term investments.

Sakar Healthcare Limited - Asset Composition Analysis

Current Asset Composition (March 2026)

Sakar Healthcare Limited's total assets of Rs4.81 Billion consist of 29.2% current assets and 70.8% non-current assets.

Asset Category Amount (INR) % of Total Assets
Cash & Equivalents Rs0.00 0.1%
Accounts Receivable Rs500.83 Million 10.4%
Inventory Rs700.41 Million 14.6%
Property, Plant & Equipment Rs0.00 0.0%
Intangible Assets Rs74.27 Million 1.5%
Goodwill Rs0.00 0.0%

Asset Composition Trend (2010–2026)

This chart illustrates how Sakar Healthcare Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Sakar Healthcare Limited market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Sakar Healthcare Limited's current assets represent 29.2% of total assets in 2026, a decrease from 30.9% in 2010.
  • Cash Position: Cash and equivalents constituted 0.1% of total assets in 2026, down from 0.6% in 2010.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2010.
  • Asset Diversification: The largest asset category is inventory at 14.6% of total assets.

Sakar Healthcare Limited Competitors by Total Assets

Key competitors of Sakar Healthcare Limited based on total assets are shown below.

Company Country Total Assets
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
China CN¥14.18 Billion
SIMCERE PHARMAC. GRP LTD
F:S2P
Germany €14.73 Billion
Curaleaf Holdings Inc.
TO:CURA
Canada CA$2.88 Billion
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
China CN¥4.44 Billion
Walvax BioTech
SHE:300142
China CN¥11.13 Billion
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
China CN¥1.54 Billion
Cronos Group Inc
TO:CRON
Canada CA$1.18 Billion
Renhe Pharmacy Co Ltd
SHE:000650
China CN¥7.93 Billion

Sakar Healthcare Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.28 1.40 1.01
Quick Ratio 0.64 0.71 0.54
Cash Ratio 0.00 0.00 0.00
Working Capital Rs309.21 Million Rs255.41 Million Rs4.54 Million

Sakar Healthcare Limited - Advanced Valuation Insights

This section examines the relationship between Sakar Healthcare Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 5.43
Latest Market Cap to Assets Ratio 0.04
Asset Growth Rate (YoY) 15.8%
Total Assets Rs4.81 Billion
Market Capitalization $188.93 Million USD

Valuation Analysis

Below Book Valuation: The market values Sakar Healthcare Limited's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Sakar Healthcare Limited's assets grew by 15.8% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Sakar Healthcare Limited (2010–2026)

The table below shows the annual total assets of Sakar Healthcare Limited from 2010 to 2026.

Year Total Assets Change
2026-03-31 Rs4.81 Billion
≈ $52.02 Million
+15.83%
2025-03-31 Rs4.15 Billion
≈ $44.91 Million
+6.84%
2024-03-31 Rs3.89 Billion
≈ $42.03 Million
+15.56%
2023-03-31 Rs3.36 Billion
≈ $36.37 Million
+25.61%
2022-03-31 Rs2.68 Billion
≈ $28.96 Million
+50.61%
2021-03-31 Rs1.78 Billion
≈ $19.23 Million
+54.44%
2020-03-31 Rs1.15 Billion
≈ $12.45 Million
+16.66%
2019-03-31 Rs986.85 Million
≈ $10.67 Million
+21.68%
2018-03-31 Rs811.00 Million
≈ $8.77 Million
+14.89%
2017-03-31 Rs705.87 Million
≈ $7.63 Million
+38.11%
2016-03-31 Rs511.10 Million
≈ $5.53 Million
+1.86%
2015-03-31 Rs501.75 Million
≈ $5.43 Million
-4.13%
2014-03-31 Rs523.37 Million
≈ $5.66 Million
+4.48%
2013-03-31 Rs500.94 Million
≈ $5.42 Million
+0.35%
2012-03-31 Rs499.20 Million
≈ $5.40 Million
+2.11%
2011-03-31 Rs488.89 Million
≈ $5.29 Million
+9.29%
2010-03-31 Rs447.35 Million
≈ $4.84 Million
--

About Sakar Healthcare Limited

NSE:SAKAR India Drug Manufacturers - Specialty & Generic
Market Cap
$188.93 Million
Rs17.47 Billion INR
Market Cap Rank
#16867 Global
#880 in India
Share Price
Rs795.90
Change (1 day)
-0.69%
52-Week Range
Rs317.10 - Rs844.15
All Time High
Rs844.15
About

Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups and injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as anti-infective, analge… Read more